Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Semin Pediatr Neurol ; 40: 100935, 2021 12.
Article in English | MEDLINE | ID: mdl-34749911

ABSTRACT

Post-traumatic headache is a secondary headache disorder beginning within 7 days of head injury. We conducted a systematic review of the evidence for treatment of post-traumatic headache in children. Of 2169 unique articles screened, 12 were included. Most studies pertained to headaches after concussion. The authors of seven studies examined the effect of medications, 4 studied nonpharmacological therapies, and 1 studied the reduction of medication usage. Much of the evidence came from retrospective chart reviews, had low level of evidence, and had fair risk of bias. High-quality randomized controlled treatment trials are needed to guide the clinical management of this condition.


Subject(s)
Brain Concussion , Post-Traumatic Headache , Child , Headache , Humans , Post-Traumatic Headache/diagnosis , Post-Traumatic Headache/etiology , Post-Traumatic Headache/therapy , Retrospective Studies
2.
Neuro Endocrinol Lett ; 41(1): 46-52, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32338852

ABSTRACT

BACKGROUND: Insulinoma as a cause of epileptic seizure has been thoroughly described but often not considered in differentials for previously established diagnoses of seizure disorder. Hypoglycemic symptoms can mimic neurological disorders such as epilepsy. CASE PRESENTATION: A 52-year-old woman presented with a history of epilepsy on anti-epileptic drugs (AEDs) developed repeated episodes consisting of seizures and neuropsychiatric symptoms with no predisposing factors for epilepsy at age 52. She had received full AED treatment before the possibility of hypoglycemia was considered. Following a clinical diagnosis of insulinoma, distal pancreatectomy was performed, and her seizures did not occur again. CONCLUSION: The early diagnosis of insulinoma requires vigilance, not only for hypoglycemia in patients with neuropsychiatric symptoms, but also for the possible masking effects of a history of epilepsy and preceding AED usage.


Subject(s)
Drug Resistant Epilepsy/diagnosis , Insulinoma/diagnosis , Pancreatic Neoplasms/diagnosis , Anticonvulsants/therapeutic use , Diagnosis, Differential , Disease Susceptibility/diagnosis , Disease Susceptibility/surgery , Drug Resistant Epilepsy/drug therapy , Drug Resistant Epilepsy/etiology , Drug Resistant Epilepsy/surgery , Female , Humans , Hypoglycemia/diagnosis , Hypoglycemia/drug therapy , Hypoglycemia/etiology , Hypoglycemia/surgery , Insulinoma/complications , Insulinoma/drug therapy , Insulinoma/surgery , Middle Aged , Pancreatectomy , Pancreatic Neoplasms/complications , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/surgery , Seizures/diagnosis , Seizures/drug therapy , Seizures/etiology , Seizures/surgery
3.
J Stroke Cerebrovasc Dis ; 28(12): 104403, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31563566

ABSTRACT

BACKGROUND: Air embolism is an extremely rare complication that can follow gastrointestinal endoscopy. The most accepted treatment of cerebral air embolism (CAE) is hyperbaric oxygen (HBO). Limited evidence suggests that lidocaine may have a neuroprotective effect. The exact mechanism does not appear to be well elucidated. METHODS: We conducted a literature search using multiple combinations of keywords from PubMed and Ovid Medline databases according to the PRISMA guidelines. We included articles with cases of air embolism caused by an esophagogastroduodenoscopy (EGD). We excluded cases related to other procedures e.g. colonoscopy, endoscopic retrograde cholangiopancreatography, cholangioscopy, Kasai procedure, bronchoscopy, laparoscopy or thoracoscopy. We were able to identify 30 cases of CAE associated with EGD. We included our experience in treating one patient with CAE after elective EGD. RESULTS: Given the results of our literature search and this patient's characteristics, we chose to treat our patient with HBO and lidocaine infusion. Our case series consists of 31 patients of post EGD CAE, the mean age was 63.7 ± 11.14 years, 38.7% of the patients were women (n = 12). 38.7% of the cases underwent esophageal dilatation (n = 12), while 19.35% had EGD biopsy (n = 6), 9.6% had variceal ligation (n = 3), and 3.22% had variceal banding (n = 1). In 20 out of 31 cases, echocardiography has been documented, 20% of those patients (n = 4) had patent foramen ovale. HBO was used in treatment of 48% of cases (n = 15), among the included patients, 61% survived (n = 19). Our patient showed significant neurological improvement. CONCLUSIONS: Despite the rare incidence of CAE during or after EGD, physicians should be aware of this potential complication. In patients who develop sudden acute neurological symptoms, early diagnosis and intervention may prevent devastating neurological injury and death. The most accepted emergent treatment for CAE includes HBO, consideration of lidocaine, and work-up of source of the air embolism.


Subject(s)
Embolism, Air , Endoscopy, Gastrointestinal/adverse effects , Intracranial Embolism , Aged , Aged, 80 and over , Embolism, Air/epidemiology , Embolism, Air/physiopathology , Embolism, Air/prevention & control , Embolism, Air/therapy , Female , Humans , Hyperbaric Oxygenation , Incidence , Infusions, Parenteral , Intracranial Embolism/epidemiology , Intracranial Embolism/physiopathology , Intracranial Embolism/prevention & control , Intracranial Embolism/therapy , Lidocaine/administration & dosage , Male , Middle Aged , Neuroprotective Agents/administration & dosage , Risk Assessment , Risk Factors , Treatment Outcome
4.
Evolution ; 67(4): 1069-80, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23550756

ABSTRACT

Male abdomen appendages are a novel trait found within Sepsidae (Diptera). Here we demonstrate that they are likely to have evolved once, were lost three times, and then secondarily gained in one lineage. The developmental basis of these appendages was investigated by counting the number of histoblast cells in each abdominal segment in four species: two that represented the initial instance of appendage evolution, one that has secondarily gained appendages, and one species that did not have appendages. Males of all species with appendages have elevated cell counts for the fourth segment, which gives rise to the appendages. In Perochaeta dikowi, which reacquired the trait, the females also have elevated cell count on the fourth segment despite the fact that females do not develop appendages. The species without appendages has similar cell counts in all segments regardless of sex. These results suggest that the basis for appendage development is shared in males across all species, but the sexual dimorphism is regulated differently in P. dikowi.


Subject(s)
Biological Evolution , Diptera/classification , Diptera/growth & development , Adnexa Uteri/cytology , Adnexa Uteri/growth & development , Animals , Diptera/anatomy & histology , Embryonic Stem Cells/cytology , Female , Genitalia, Male/cytology , Genitalia, Male/growth & development , Male , Phylogeny , Sex Characteristics
SELECTION OF CITATIONS
SEARCH DETAIL